Consistent with these findings, the present study suggests that, during the pre-chemotherapy assessment, TNF-α levels were highly responsive to surgical tumor removal, contributing to the lower inflammatory profile observed in the adjuvant group compared with the neoadjuvant group. This evidence concerns the gene TNF and neoplasm.